0001567619-22-009717.txt : 20220506 0001567619-22-009717.hdr.sgml : 20220506 20220506194549 ACCESSION NUMBER: 0001567619-22-009717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220429 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mueller Brian CENTRAL INDEX KEY: 0001514980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 22902885 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2022-04-29 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001514980 Mueller Brian 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2022-04-29 5 A 0 340 62.407 A 38639 D Common Stock 2022-05-04 4 M 0 2038 37.46 A 40677 D Common Stock 2022-05-04 4 S 0 2038 84.5 D 38639 D Common Stock 2022-05-04 4 M 0 9762 37.46 A 48401 D Common Stock 2022-05-04 4 S 0 9762 84.5 D 38639 D Stock Option (Right to buy Common Stock) 37.46 2022-05-04 4 M 0 2038 0 D 2012-11-08 2022-05-07 Common Stock 2038 0 D Stock Option (Right to buy Common Stock) 37.46 2022-05-04 4 M 0 9762 0 D 2012-11-08 2022-05-07 Common Stock 9762 0 D Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan. Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2022-05-06